← Back to Clinical Trials
Recruiting NCT05820919

NCT05820919 Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05820919
Status Recruiting
Phase
Sponsor University of Alabama, Tuscaloosa
Condition Alzheimer Disease
Study Type INTERVENTIONAL
Enrollment 456 participants
Start Date 2023-09-07
Primary Completion 2026-04-01

Trial Parameters

Condition Alzheimer Disease
Sponsor University of Alabama, Tuscaloosa
Study Type INTERVENTIONAL
Phase N/A
Enrollment 456
Sex ALL
Min Age 50 Years
Max Age N/A
Start Date 2023-09-07
Completion 2026-04-01
Interventions
LOCK Sleep ProgramNo intervention (control period/baseline data collection)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study seeks to improve clinical outcomes for an important, growing, and vulnerable population-nursing home residents with Alzheimer's disease or related dementias-by testing an evidence-based intervention to improve these residents' sleep. It will also examine the implementation and sustainment of this intervention.

Eligibility Criteria

Inclusion Criteria: * Nursing home residents aged \>=50 years with an Alzheimer disease or related dementia (ADRD) diagnosis, identified by nursing home staff participating in frontline LOCK sleep huddles as having sleep problems Exclusion Criteria: * Residents with a high risk of OSA who are not being treated for OSA because actigraph measurements are inaccurate in that population. * Residents who have a persistent bilateral resting tremor or paralysis in both arms (a subset of persons with Parkinson's disease and related significant tremor-causing diagnoses), due to actigraph measurement inaccuracies

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology